Vaccination against hepatitis B and C: towards therapeutic application.
Inchauspe
Genevieve
G
Transgene SA, Strasbourg, France. inchauspe@transgene.fr
Bach
Guillaume
G
Martin
Perrine
P
Bonnefoy
Jean Yves
JY
D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000821:virology; D006509:Hepatitis B / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000276:immunology / Q000627:therapeutic use*; D006526:Hepatitis C / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D014611:Vaccination; D019444:Vaccines, DNA / Q000276:immunology / Q000627:therapeutic use*; D014761:Viral Hepatitis Vaccines / Q000276:immunology / Q000627:therapeutic use*
D017325:Hepatitis B Vaccines; D019444:Vaccines, DNA; D014761:Viral Hepatitis Vaccines